Find stats on top websites
Major Markets
Charles River Laboratories
Lonza
Thermo Fisher Scientific (Patheon)
Charles River Laboratories
Broad portfolio of preclinical and drug discovery services
Strong reputation in safety assessment and vivarium services
Extensive client base including large pharma and biotech.
May be perceived as less specialized in advanced manufacturing (CDMO) compared to some competitors
Global footprint might be less integrated than pure-play CDMOs
Potential for high operating costs given extensive research facilities.
Growing demand for outsourced early-stage research
Expansion into new therapeutic areas like gene therapy
Leveraging AI/ML for drug discovery acceleration.
Intense competition from other CROs and CDMOs
Regulatory changes impacting preclinical testing
Economic downturns affecting R&D budgets.
Sign up now and unleash the power of AI for your business growth